Showing results (281-290 of 384) with videos related to

Sort By:
Pageof 39
Autophagy|March 15, 2013
Autophagy in stem cellsJun-Lin Guan, Anna Katharina Simon, Mark Prescott, et al.
Scientific Reports|August 23, 2013
The anti-malarial chloroquine overcomes primary resistance and restores sensitivity to trastuzumab in HER2-positive breast cancerSílvia Cufí, Alejandro Vazquez-Martin, Cristina Oliveras-Ferraros, et al.
Stem Cell Reports|February 16, 2016
Oncometabolic Nuclear Reprogramming of Cancer StemnessJavier A Menendez, Bruna Corominas-Faja, Elisabet Cuyàs, et al.
Oncotarget|March 10, 2016
Response of brain metastasis from lung cancer patients to an oral nutraceutical product containing silibininJoaquim Bosch-Barrera, Elia Sais, Noemí Cañete, et al.
Journal of Proteome Research|September 30, 2022
Optimization of a GC-MS Injection-Port Derivatization Methodology to Enhance Metabolomics Analysis Throughput in Biological SamplesElisabet Foguet-Romero, Iris Samarra, Maria Guirro, et al.
Oncology Letters|February 20, 2013
Synchronous solid neuroendocrine breast carcinoma and abdominal lymphoma: A case report and review of the literatureMiguel Alonso-Ruano, Eugeni López-Bonet, Maria Victoria Huerta-Anaya, et al.
Cancers|April 3, 2021
Fatty Acid Synthase Confers Tamoxifen Resistance to ER+/HER2+ Breast CancerJavier A Menendez, Adriana Papadimitropoulou, Travis Vander Steen, et al.
Oncotarget|May 19, 2015
Oncometabolic mutation IDH1 R132H confers a metformin-hypersensitive phenotypeElisabet Cuyàs, Salvador Fernández-Arroyo, Bruna Corominas-Faja, et al.
Journal of Cellular Biochemistry|November 25, 2010
Stem cell property epithelial-to-mesenchymal transition is a core transcriptional network for predicting cetuximab (Erbitux™) efficacy in KRAS wild-type tumor cellsCristina Oliveras-Ferraros, Alejandro Vazquez-Martin, Sílvia Cufí, et al.
Pageof 39